Amita Mercy Medical Center is an addiction treatment center situated at 1325 North Highland Avenue in the 60506 zip code of Aurora, IL.
It is run by a private non-profit organization. Amita Mercy Medical Center offers relapse prevention from naltrexone, prescribes suboxone and buprenorphine detox. Amita Mercy Medical Center provides regular outpatient treatment, outpatient detox services and outpatient methadone/buprenorphine or naltrexone treatment. Some of the treatment approaches used by Amita Mercy Medical Center include substance use counseling approach, DBT and brief intervention. Amita Mercy Medical Center also provides detox services that include inpatient alcohol detoxification, methamphetamines detox and cocaine detox. It provides inpatient dual diagnosis treatment, residential treatment for substance use and inpatient detox services.
Here are the full facility listing details on Amita Mercy Medical Center in Aurora, IL:
Types of Care:
- inpatient detoxification
- residential substance use treatment
- inpatient treatment for dual diagnosis
Service Settings:
- outpatient rehab
- outpatient detox services
- outpatient day treatment
- intensive outpatient treatment program
- outpatient methadone/buprenorphine or naltrexone treatment
- regular outpatient treatment
Hospitals:
Opioid Medications used in Treatment:
- Buprenorphine clinical treatment
- Naltrexone treatment
External Opioid Medications Source:
- Personal physician/health care provider
Type of Alcohol Use Disorder Treatment:
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- Administers medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment:
- Personal physician/health care provider
Type Of Treatment:
- buprenorphine detox
- prescribes suboxone
- administers naltrexone
- relapse prevention from naltrexone
Pharmacotherapies:
- Acamprosate (Campral)
- Disulfiram (Antabuse)
- Buprenorphine with naloxone (Ex. Suboxone)
- Buprenorphine without naloxone
- Naltrexone (oral)
- Naltrexone (extended-release, injectable naltrexone - Vivitrol)
- Medications for psychiatric disorders
- Clonidine
Treatment Approaches:
- anger management
- brief intervention
- CBT
- dialectical behavior therapy
- motivational interviewing
- relapse prevention treatment
- substance use counseling approach
- counseling for trauma victims
- 12-step rehab
Facility Ownership:
- a private non-profit organization
License/Certification/Accreditation:
- Hospital licensing authority
- Certified by The Joint Commission
Payment/Insurance/Funding Accepted:
- Accepts Medicare
- Accepts Medicaid
- Accepts private health insurance
- Accepts cash or self-payment
Assessment/Pre-treatment:
- Comprehensive mental health assessment
- Comprehensive substance use assessment
- Outreach to persons in the community
Screening & Testing:
- Breathalyzer or blood alcohol testing
- Drug or alcohol urine screening
- HIV testing
- Screening for Hepatitis B
- Screening for Hepatitis C
- Screening for mental disorders
- Screening for substance use
- STD testing
- TB screening
Transitional Services:
- Aftercare/continuing care
- Discharge Planning
- Naloxone and overdose education
Ancillary Services:
- Case management
- Mental health services
- Self-help groups
- Social skills development
- Mentoring/Peer support
Detoxification:
- inpatient alcohol detoxification
- residential benzodiazepines detoxification
- cocaine detoxification
- methamphetamines detox
- inpatient opioid detox
Counseling Services and Education:
- individual counseling services
- counseling for groups
- family counseling
- counseling for couples
- substance use education
- hepatitis education, counseling and support
- HIV and AIDS support
- health education services
- educational support
Tobacco/Screening Services:
- Nicotine replacement therapy
- Non-nicotine smoking/tobacco cessation medications
- Screening for tobacco use
- Smoking/tobacco cessation counseling
Facility Smoking Policy:
Age Groups Accepted:
- adult rehab
- accepts young adults
Gender Accepted:
